Fig 1.
Flow chart of patient selection.
FCSEMS, fully covered self-expandable metal stent; RT, radiotherapy.
Table 1.
Comparison of baseline characteristics between esophageal cancer patients who received either esophageal self-expanding metal stent or percutaneous gastrostomy for malignant dysphagia.
Fig 2.
(A) Kaplan-Meier curves for overall survival in stage II and III esophageal cancer patients who received either esophageal self-expanding metal stent or percutaneous gastrostomy for malignant dysphagia. (B) Kaplan-Meier curves for overall survival in stage IV esophageal cancer patients who received either esophageal self-expanding metal stent or percutaneous gastrostomy for malignant dysphagia.
Table 2.
Prognostic factors associated with overall survival in patients with esophageal cancer and dysphagia.
Table 3.
Comparison of secondary outcomes between esophageal cancer patients who received either esophageal self-expanding metal stent or percutaneous gastrostomy for malignant dysphagia.